| NRP1 | Neuropilin1 |
| NRP’s | Neuropilins |
| VEGF | vascular endothelial growth factor |
| TGF-β | transforming growth factor-beta |
| pDC | plasmacytoid dendritic cells. |
| BMP-1 | bone morphogenetic protein |
| CUB | extracellular complement binding |
| LAP-TGFβ | Latency associated peptide-TGFβ. |
| VEGFR2 | Vascular endothelial growth factor receptor 2. |
| HGF | Hepatic growth factor. |
| PDGF | Platelet-derived growth factor |
| VMSC | Vascular smooth muscle cells |
| FGF2 | Fibroblast growth factor2 |
| PIGF | Placental growth factor |
| PDZ | Postsynaptic density protein (PSD95), Drosophila disc large tumor suppressor (Dlg1), and zonula occludens-1 protein (zo-1) |
| GIPC | GAIP interacting protein, C terminus |
| RAC | Ras-related C3 botulinum toxin substrate 1 |
| GTP | Guanosine triphosphate. |
| MAPK | Map kinase. |
| ABL-1 | Protooncogene 1, non-receptor tyrosine kinase gene |
| CDC 42 | Cell division cycle 42 |
| EMT | Epithelial–Mesenchymal Transition |
| PECAM-1 | Platelet Endothelial Cell Adhesion Molecule 1 |
| MMP9 | Matrix Metalloprotein 9 |
| GO/KEGG | Gene Ontology/Kyoto Encyclopedia of Genes and Genomics |
| IPA | Ingenuity Pathway Analysis. |
| CRISPR/CAS9 | Clustered regularly interspaced palindromic repeats |
| PAAD | Pancreatic adenocarcinoma. |
| PDAC | Pancreatic Ductal Adeno Carcinoma. |
| NKT | Natural Killer cells |
| CAF | Cancer-associated Fibroblasts |
| KIRC | Kidney Renal Cell Carcinoma |
| SKCM | Skin Cutaneous Melanoma |
| RCC | Renal cell Carcinoma. |
| ccRCC | Clear cell Renal Cell Carcinoma |
| mTOR | Rapamycin. |
| TTP | Tumor targeting peptides |
| ER- | negative Breast Cancer—Estrogen Receptor-negative Breast Cancer. |
| ZEB1 | Zinc Finger E-box Binding Homeobox 1 |
| ITGα 6 | Integrin subunit alpha 6 |
| PDGFR | Platelet-derived growth factor receptor |
| NFκB | Nuclear factor kappa B |
| BRCA | Breast Cancer Genes |
| (CTLA-4) | Cytotoxic T-Lymphocyte-Associated Protein 4 |
| PD-1 | Programmed Cell Death Protein 1 |